Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Xenon Pharmaceuticals Inc (XENE)

$13.36 1.29 (8.81%)

18:48 EST XENE Stock Quote Delayed 15 Minutes

Volume:

Previous Close $13.36

Market Cap 235.30M

PE Ratio -8.91

EPS -1.5

Volume (Avg. Vol.) 137,306

Day's Range 13.18 - 14.65

52-Week Range 5.41 - 14.95

Dividend & Yield N/A (N/A)

XENE Stock Predictions, Articles, and Xenon Pharmaceuticals Inc News

From InvestorPlace
From the Web

Xenon Pharmaceuticals Inc (XENE) Plunges on Acne Drug Flop

By William White, InvestorPlace Writer Mar 24, 2017

Xenon Pharmaceuticals (XENE) stock was falling hard on Friday following results from a recent study of its acne drug XEN801.

The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint

From Benzinga Dec 11, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) Acceleron Pharma Inc (...

Stocks That Hit 52-Week Highs On Tuesday

From Benzinga Dec 10, 2019

During Tuesday, 224 stocks hit new 52-week highs. Noteables: The largest company by market cap to hit a new 52-week high was Morgan Stanley Emerg Mkts (NYSE: MSD). The smallest...

50 Stocks Moving In Thursday's Mid-Day Session

From Benzinga Dec 5, 2019

Gainers Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) shares climbed 86.4% to $15.64 after the company reported positive clinical readout for its lead asset voclosporin in...

The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission

From Benzinga Dec 5, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) Allakos Inc (NASDAQ: ALLK...

Stocks That Hit 52-Week Highs On Wednesday

From Benzinga Dec 4, 2019

Wednesday's morning session saw 124 companies set new 52-week highs. Highlights: Merck & Co (NYSE: MRK) was the largest company by market cap to set a new 52-week high....

The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug

From Benzinga Dec 4, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 3) Alnylam Pharmaceuticals,...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy